Skip to content

Evaluation of an Universal Surgical Device for Mandibular Reconstruction.

Universal Surgical Device for Mandibular Reconstruction Using Fibula Free Flap : Feasibility Study.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06238076
Acronym
FIBUMAND
Enrollment
19
Registered
2024-02-02
Start date
2024-03-28
Completion date
2026-05-31
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mandibular Reconstruction

Keywords

Mandible, Mandibular Reconstruction, Computer-Aided Design, Fibular free flap, Computer Assisted three dimensional imaging, Surgical equipment

Brief summary

Fibula free flap is the gold standard for mandibular reconstruction. The shape of the fibula requires osteotomy that can be performed with a custom surgical guide. The use of surgical guide shorten surgical time, enhances the precision of the surgeon and reduces morbidity. Since 2008 custom surgical guide have been used in the hospital department and the clinical team have noticed a number of elements, which leads investigator to think that it would be possible to perform this kind of procedure using an universal guide. The aim of this study is to assess the possibility to perform mandibular fibula free flap reconstruction with an universal guide.

Interventions

DEVICEUniversal surgical device FIBUMAND

This device is made of biocompatible resin for type IIa medical devices with a 3D printer.

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Feasibility pilot study, monocentric, non-comparative

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admitted in the maxillofacial surgery department for mandibular fibula free flap reconstruction including a symphysial bone fragment * Patients insured under the French social security system * Free and informed consent

Exclusion criteria

* Lateral mandibular reconstruction without symphysis reconstruction * Legally incompetent * Inclusion in another protocol of research , involving mandibular reconstruction * Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of guiding mandibular fibula free flap reconstruction with an universal guide.Day 1Either the surgeon assists the entire procedure using the device and the patient is registered as success, or the device is not suitable and cannot be used and the patient is registered as failure . Partial use is also considered a failure of the procedure.

Secondary

MeasureTime frameDescription
Time of surgical procedureDay 1It is timed (in minutes) during the procedure and relative to the total duration of the intervention.
Qualitative assessment of the device by the surgeonDay 1Evaluation of the general appreciation according a 4-point scale (very unsatisfactory / unsatisfactory / satisfactory / excellent) about the: * The positioning and fixing of the guide, * Performing osteotomies, * The use of the meter, * The congruence of the bone surfaces, * The use of the plate shaper, * Fibular osteosynthesis, * The mandibular reconstruction obtained
Post-operative quality of lifeFrom 6 to 8 weeksThe patient's postoperative quality of life will be assessed by the University of Washington Quality of Life Questionnaire (UW-QOL) version 4.0. UW-QOL questionnaire consists of 12 single question domains, these having between 3 and 6 response options that are scaled evenly from 0 (worst) to 100 (best) according to the hierarchy of response. The domains are pain, appearance, activity, recreation, swallowing, chewing, speech, shoulder, taste, saliva, mood and anxiety. Another question asks patients to choose up to three of these domains that have been the most important to them. There are also three global questions, one about how patients feel relative to before they developed their cancer, one about their health-related QOL and one about their overall QOL.The whole questionnaire focuses on current patient health and quality of life within the past 7 days.

Countries

France

Contacts

Primary ContactAlice PREVOST, MD
prevost.a@chu-toulouse.fr+335 61 77 95 43
Backup ContactFrédéric LAUWERS, MD
lauwers.f@chu-toulouse.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026